Switching to Another Oral Anticoagulant and Drug Discontinuation Among Elderly Patients With Nonvalvular Atrial Fibrillation Treated With Different Direct Oral Anticoagulants

We compared the risks of switching to another oral anticoagulant (OAC) and discontinuation of direct oral anticoagulants (DOACs) among elderly patients with nonvalvular atrial fibrillation (NVAF) who were prescribed rivaroxaban or dabigatran versus apixaban. Patients (≥65 years of age) with NVAF pre...

Full description

Saved in:
Bibliographic Details
Published in:Clin Appl Thromb Hemost
Main Authors: Baker, Christine L., Dhamane, Amol D., Rajpura, Jigar, Mardekian, Jack, Dina, Oluwaseyi, Russ, Cristina, Rosenblatt, Lisa, Lingohr-Smith, Melissa, Lin, Jay
Format: Artigo
Language:Inglês
Published: SAGE Publications 2019
Subjects:
Original Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6829636/
https://ncbi.nlm.nih.gov/pubmed/31418293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029619870249
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items